Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease

被引:276
作者
Lomer, MCE
Thompson, RPH
Powell, JJ
机构
[1] St Thomas Hosp, Rayne Inst, Gastrointestinal Lab, London SE1 7EH, England
[2] Kings Coll London, Dept Nutr, London SE1 8WA, England
关键词
dietary microparticles; Crohn's disease;
D O I
10.1079/PNS2001134
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Crohn's disease is a modem Western disease characterised by transmural inflammation of the gastrointestinal tract. It is of unknown aetiology, but evidence suggests that it results from a combination of genetic predisposition and environmental factors. Bacterial-sized microparticles (0.1-1.0 mum) are potent adjuvants in model antigen-mediated immune responses and are increasingly associated with disease. Microparticles of TiO2 and aluminosilicate accumulate in macrophages of human gut-associated lymphoid tissue where the earliest signs of lesions in Crohn's disease are observed. Dietary microparticles are of endogenous or exogenous origin. Endogenous microparticles dominate and are calcium phosphate (most probably hydroxyapatite), which precipitates in the lumen of the mid-distal gastrointestinal tract due to secretion of Ca and phosphate in the succus entericus, Exogenous dietary microparticles are contaminants (soil and/or dust) and food additives. TiO2, for example, is a food colourant, and alummosilicates are anti-caking agents, although some aluminosilicates occur as natural contaminants. Food additives alone account for ingestion of approximately 10(12) particles/person per d. Possible mechanisms for the role of exogenous and endogenous dietary microparticles in promoting toleragenic or immune responses of gastrointestinal mucosal phagocytosis are discussed. In a double-blind randomised pilot study we have shown that a diet low in Ca and exogenous microparticles appears to alleviate the symptoms of ileal Crohn's disease, with a significant (P = 0.002) improvement in the Crohn's disease activity index. A multi-centre trial and further mechanistic studies at the cellular level are underway.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 57 条
[41]   TREATMENT OF ACTIVE CROHNS-DISEASE BY EXCLUSION DIET - EAST ANGLIAN MULTICENTER CONTROLLED TRIAL [J].
RIORDAN, AM ;
HUNTER, JO ;
COWAN, RE ;
CRAMPTON, JR ;
DAVIDSON, AR ;
DICKINSON, RJ ;
DRONFIELD, MW ;
FELLOWS, IW ;
HISHON, S ;
KERRIGAN, GNW ;
KENNEDY, HJ ;
MCGOURAN, RCM ;
NEALE, G ;
SAUNDERS, JHB .
LANCET, 1993, 342 (8880) :1131-1134
[42]   'Modern life' in the epidemiology of inflammatory bowel disease: A case-control study with special emphasis on nutritional factors [J].
Russel, MG ;
Engels, LG ;
Muris, JW ;
Limonard, CB ;
Volovics, A ;
Brummer, RJM ;
Stockbrugger, RW .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (03) :243-249
[43]   EFFECT OF FECAL STREAM DIVERSION ON RECURRENCE OF CROHNS-DISEASE IN THE NEOTERMINAL ILEUM [J].
RUTGEERTS, P ;
GOBOES, K ;
PEETERS, M ;
HIELE, M ;
PENNINCKX, F ;
AERTS, R ;
KERREMANS, R ;
VANTRAPPEN, G .
LANCET, 1991, 338 (8770) :771-774
[44]   Fine particulate air pollution and mortality in 20 US Cities, 1987-1994. [J].
Samet, JM ;
Dominici, F ;
Curriero, FC ;
Coursac, I ;
Zeger, SL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24) :1742-1749
[45]   ABSORPTION SECRETION AND PRECIPITATION OF CALCIUM IN SMALL INTESTINE OF DOG [J].
SCHEDL, HP ;
OSBALDIS.GW ;
MILLS, IH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1968, 214 (04) :814-+
[46]   ROLE OF INTRALUMINAL PRECIPITATION IN SECRETION OF SMALL INTESTINAL CALCIUM AND PHOSPHATE IN DOG [J].
SCHEDL, HP ;
OSBALDIS.GW ;
MILLS, IH .
NATURE, 1967, 215 (5097) :198-&
[47]   Lack of T(h)1 or T(h)2 polarization of CD4(+) T cell response induced by particulate antigen targeted to phagocytic cells [J].
Sedlik, C ;
Deriaud, E ;
Leclerc, C .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (01) :91-103
[48]   EXOGENOUS PIGMENT IN PEYERS-PATCHES [J].
SHEPHERD, NA ;
CROCKER, PR ;
SMITH, AP ;
LEVISON, DA .
HUMAN PATHOLOGY, 1987, 18 (01) :50-54
[49]  
Song R, 1996, J IMMUNOL, V156, P4182
[50]  
Stryhn A, 1996, J IMMUNOL, V156, P4191